Table 1. Patient characteristics, epidemiological and clinical variables associated with ESBL positive Escherichia coli and Klebsiella species CA-UTI (univariate analysis).
| Patient data | ESBL (+) (n=66) | ESBL (−) (n=112) | p-value |
|---|---|---|---|
| Sex | >0.05 | ||
| Male | 39 (59.1 ) | 35 (31.3) | |
| Female | 27 (40.9) | 77 (68.8) | |
| Age (y) | <0.05 | ||
| <60 | 27 (40.9) | 64 (57.1) | |
| >60 | 39 (59.1) | 48 (42.9) | |
| Type of infection | >0.05 | ||
| Uncomplicated | 36 (54.5) | 48 (42.9) | |
| Complicated | 30 (45.5) | 64 (57.1) | |
| Comorbidity | >0.05 | ||
| Diabetes mellitus | 19 (28.8) | 23 (20.5) | |
| Hypertension | 32 (48.5) | 41 (36.6) | |
| Chronic cardiovascular disease | 6 (9.1) | 12 (10.7) | |
| Chronic renal disease | 9 (13.6) | 8 (7.1) | |
| Another systemic diseasesa | 17 (25.8) | 17 (15.2) | |
| Urinary system malignancy | 6 (9.1) | 4 (3.6) | >0.05 |
| Urolithiasis | 22 (33.3) | 16 (14.3) | <0.05 |
| Urinary tract abnormalitiesb | 27 (40.9) | 24 (24.1) | |
| History of urinary catheterization | 36 (54.5) | 29 (25.9) | |
| Recurrent UTI | 18 (27.3) | 12 (10.7) | |
| History of urological surgery | 13 (19.7) | 8 (7.1) | |
| History of invasive urological procedures | 19 (28.8) | 7 (6.3) | |
| History of hospitalization in last 3 months | 15 (27.3) | 9 (8.0) | |
| History of hospitalization in last one year | 11 (16.7) | 11 (9.8) | |
| History of antibiotic use in last 3 months | 33 (50.0) | 38 (33.9) |
Values are presented as number (%).
ESBL, extended-spectrum β-lactamase; CA-UTI, community-acquired urinary tract infection.
a:Rheumatoid arthritis, Behcet disease, Gout disease.
b:Vesicoureteral reflux, benign prostatic hypertrophy, sistosel, neurogenic bladder.